PCM
TNDM icon

Peregrine Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Peregrine Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-243,355
Closed -$5.05M – 325
2023
Q3 		$5.05M Buy
243,355
+52,897
+28% +$1.45M 0.15% 229
2023
Q2 		$4.67M Sell
190,458
-58
-0% -$1.87K 0.13% 242
2023
Q1 		$7.74M Buy
190,516
+5,619
+3% +$233K 0.22% 200
2022
Q4 		$8.31M Sell
184,897
-5,594
-3% -$253K 0.26% 180
2022
Q3 		$9.12M Buy
+190,491
New +$10.4M 0.3% 143

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Peregrine Capital Management's TNDM Position: Q4 2023 in Review

Peregrine Capital Management sold out of Tandem Diabetes Care (TNDM) in Q4 2023, closing a stake of 243,355 shares — an estimated $5.05M sold.

Peregrine Capital Management first reported a position in TNDM in Q3 2022 and held it in 5 quarters. The position peaked at $9.12M in Q3 2022. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2023.

  • Peregrine Capital Management reported no remaining Tandem Diabetes Care position as of Q4 2023 after selling out during the quarter.
  • Peregrine Capital Management sold 243,355 Tandem Diabetes Care shares in Q4 2023, an estimated $5.05M.
  • Peregrine Capital Management first reported a position in Tandem Diabetes Care in Q3 2022 and held it in 5 quarters.
  • Peregrine Capital Management's Tandem Diabetes Care position peaked at $9.12M in Q3 2022.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2023.

Based on Peregrine Capital Management's 13F filing for Q4 2023, filed 26 Jan 2024.